LFCR FY 2023 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$103M-7.2% YoY

Gross Profit

$28M27.1% margin

Operating Income

-$22M-21.1% margin

Net Income

-$100M-96.4% margin

EPS (Diluted)

$-3.32

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$39M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$254M

Total Liabilities

$258M

Stockholders' Equity

-$4M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103M	$111M	-7.2%
Gross Profit	$28M	$39M	-28.4%
Operating Income	-$22M	-$12M	-84.9%
Net Income	-$100M	-$117M	+14.7%